Advertisement

Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Europe and Israel or involving organisations from these countries.

Total search results: 6676 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 65 66 67  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Monument Therapeutics–o2h: investment, 202107 seed financing round totalling £2.625m incl co- investor o2h Ventures 2021-07-01
Monument Therapeutics–OTHER: investment, 202107 seed financing round totalling £2.625m incl angel investors as co- investors 2021-07-01
Monument Therapeutics–SEVERAL: investment, 202107 seed financing round £2.625m led by GM&C Life Sciences Fund to spin out from Cambridge Cognition 2021-07-01
Monument Therapeutics–Wren Capital: investment, 202107 seed financing round totalling £2.625m incl co- investor Wren Capital 2021-07-01
Nestlé–Seres Therapeutics: microbiome-based drug, 202107– license North America $175m upfront + $350m milestones + 50% of commercial profits 2021-07-01
Zukunftsfonds Heilbronn–Ampersand: investment, 202107 acquisition of majority share in PPS from ZFHN and merger with portfolio company GeneWerk 2021-07-01
NFL Biosciences–SEVERAL: investment, 202106–202107 IPO €5m at Euronext Growh Paris with 486.2k shares in France + 829.6k shares globally at €3.8/share 2021-06-30
Promethera–SEVERAL: investment, 202106– financing round €20m incl €10m from Shang Ying Intl Holdings Ltd (HK) 2021-06-30
Orbit Discovery–Zyme Communications: public relations, 202106 service existent by Zyme 2021-06-29
United Kingdom (govt)–Univ Edinburgh: CAGT manufacturing, 202106– collab establishment of CGT Catapult Edinburgh at EdinBurgh BioQuarter 2021-06-29
Xenothera–EU (govt): investment, 202106 financing round totalling €20m incl €10m from new + lead investor EIC Fund 2021-06-29
Xenothera–SEVERAL: investment, 202106 financing round €20m led by new investor EIC Fund with €10m 2021-06-29
BMS–WPP: public releations, 202106c supply service BMS is among largest + long-term health clients of Ogilvy Health 2021-06-28
Boehringer–WPP: public releations, 202106c supply service Boehringer is among largest + long-term health clients of Ogilvy Health 2021-06-28
Merck (US)–WPP: public releations, 202106c supply service Merck is among largest + long-term health clients of Ogilvy Health 2021-06-28
Pfizer–WPP: public releations, 202106c supply service Pfizer is among largest + long-term health clients of Ogilvy Health 2021-06-28
Polyphor–LifeSci: public relations, 202106 supply service existent LifeSci Advisors is media + IR contact for Polyphor 2021-06-28
Discover Echo–Cellink: investment, 202106– acquisition $110m with $98m in cash + $12m in new Series B shares ANNOUNCED 2021-06-26
Pixium Vision–LifeSci: public relations, 202106 supply service existent LifeSci Advisors is media + IR contact for Pixium Vision 2021-06-25
EQRx–Exscientia: AI-based drug discovery, 202106– strategic collab r+d + commerc with equally shared costs 2021-06-24
Merck (DE)–Nucleai MD: AI-based biomarker discovery, 202106– long-term collab using ATOM platform for cancer biomarker discovery 2021-06-24
RheinCell Therapeutics–Catalent: investment, 202106– acquisition of RheinCell by Catalent ANNOUNCED 2021-06-24
Cambridge Cancer Genomics–Dante Labs: investment, 202106 acquisition of CCG.ai by Dante Labs 2021-06-23
FundaMental Pharma–High-Tech Gründerfonds: investment, 202106 seed funding from HTGF 2021-06-23
Leukocare–Petrichor Healthcare: credit, 202106– convertible loan totalling $15m incl Petrichor HCM 2021-06-23
Leukocare–Petrichor Healthcare: investment, 202106 equity investment $2.5m from Petrichor HCM 2021-06-23
Leukocare–SEVERAL: credit, 202106– convertible loan $15m led by Petrichor HCM + incl existing shareholders 2021-06-23
Monte Rosa Therapeutics–SEVERAL: investment, 202106 IPO $222.3m+$33.345m with 11.7m+1.755m shares common stock at Nasdaq Global Select Market 2021-06-23
Paramit–Tecan: investment, 202106– acquisition $1b from Altaris Capital Partners LLC ANNOUNCED 2021-06-23
908 Devices–Sartorius: bioprocess control technology, 202106 collab product integration Rebel media analyzer with SIMCA data exploratory tool 2021-06-22
908 Devices–Securecell: bioprocess control technology, 202106 collab product integration Rebel media analyzer with Lucullus PIMS 2021-06-22
Corlieve Therapeutics–Uniqure: investment, 202106– acquisition €46.3m upfront cash + €203.7m milestones ANNOUNCED 2021-06-22
NeuVasQ Biotechnologies–Newton Biocapital: investment, 202106 financing round Series A totalling €20m incl lead investor Newton Biocapital I 2021-06-22
NeuVasQ Biotechnologies–SEVERAL: investment, 202106 financing round Series A €20m led by Newton Biocapital I 2021-06-22
Sirion Biotech–PerkinElmer: investment, 202106– acquisition by PerkinElmer ANNOUNCED 2021-06-22
Owler–Meltwater: investment, 202106– acquisition $24.5m with $18.9m in cash + $5.6m in equity ANNOUNCED 2021-06-18
Aldevron–Danaher: investment, 202106– acquisition $9.6b in cash by Danaher ANNOUNCED 2021-06-17
Apollo Therapeutics Fund–SEVERAL: investment, 202106 financing round $145m led by Patient Square Capital taking controlling equity position 2021-06-17
Chemic Laboratories–Solvias: investment, 202106 acquisition €na by Solvias 2021-06-17
Kahr-Medical–aMoon: investment, 202106 financing round totalling $46.5m incl lead investor aMoon 2021-06-16
Kahr-Medical–BVF Partners: investment, 202106 financing round totalling $46.5m incl new + co-investor BVF Partners LP 2021-06-16
Kahr-Medical–Cancer Focus Fund: investment, 202106 financing round totalling $46.5m incl new + co-investor Cancer Focus Fund 2021-06-16
Kahr-Medical–Dafna Capital: investment, 202106 financing round totalling $46.5m incl new + co-investor Dafna Capital Management LLC 2021-06-16
Kahr-Medical–Flerie Invest: investment, 202106 financing round totalling $46.5m incl existing + co-investor Flerie Invest AB 2021-06-16
Kahr-Medical–Hadasit Bio-Holdings: investment, 202106 financing round totalling $46.5m incl existing + co-investor Hadasit Bio Holdings Ltd 2021-06-16
Kahr-Medical–Mirae Asset: investment, 202106 financing round totalling $46.5m incl existing + co-investor Mirae Asset 2021-06-16
Kahr-Medical–Oriella: investment, 202106 financing round totalling $46.5m incl existing + co-investor Oriella Ltd 2021-06-16
Kahr-Medical–Pavilion Capital: investment, 202106 financing round totalling $46.5m incl existing + co-investor Pavilion Capital 2021-06-16
Kahr-Medical–Peregrine Ventures: investment, 202106 financing round totalling $46.5m incl new + co-investor Peregrine Ventures 2021-06-16
Kahr-Medical–SEVERAL: investment, 202106 financing round $46.5m led by aMoon 2021-06-16
Kahr-Medical–Shavit Capital: investment, 202106 financing round totalling $46.5m incl new + co-investor Chavit Capital 2021-06-16
Mnemo Therapeutics–Alexandria Real Estate: investment, 202106 financing round Series A totalling €75m incl co-investor Alexandria Venture Investments 2021-06-16
Mnemo Therapeutics–Casdin Capital: investment, 202106 financing round Series A totalling €75m incl co-lead investor Casdin Capital 2021-06-16
Mnemo Therapeutics–Emerson Collective: investment, 202106 financing round Series A totalling €75m incl co-investor Emerson Collective 2021-06-16
Mnemo Therapeutics–OTHER: investment, 202106 financing round Series A totalling €75m incl co-lead by undisclosed investor 2021-06-16
Mnemo Therapeutics–Redmile Group: investment, 202106 financing round Series A totalling €75m incl co-investor Redmile Group 2021-06-16
Mnemo Therapeutics–SEVERAL: investment, 202106 financing round Series A €75m led by Casdin Capital + Sofinnova Partners + NN 2021-06-16
Mnemo Therapeutics–Sofinnova: investment, 202106 financing round Series A totalling €75m incl existing + co-lead investor Sofinnova Partners 2021-06-16
Ochre Bio–Apollo Ventures: investment, 202106 seed financing round totalling $9.6m incl co-investor Apollo Health Ventures 2021-06-16
Ochre Bio–Backed VC: investment, 202106 seed financing round totalling $9.6m incl co-investor Backed VC 2021-06-16
Ochre Bio–Hermes-Epitek: investment, 202106 seed financing round totalling $9.6m incl co-investor Hermes-Epitek 2021-06-16
Ochre Bio–Hoxton: investment, 202106 seed financing round totalling $9.6m incl co-investor Hoxton 2021-06-16
Ochre Bio–Khosla Ventures: investment, 202106 seed financing round totalling $9.6m incl lead investor Khosla Ventures 2021-06-16
Ochre Bio–Selvedge: investment, 202106 seed financing round totalling $9.6m incl co-investor Selvedge 2021-06-16
Ochre Bio–SEVERAL: investment, 202106 seed financing round $9.6m led by Khosla Ventures 2021-06-16
Alentis Therapeutics–Bellevue: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor BB Pureos Bioventures 2021-06-15
Alentis Therapeutics–BioMedPartners: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor BioMed Partners 2021-06-15
Alentis Therapeutics–France (govt): investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor Bpifrance InnoBio 2 Fund 2021-06-15
Alentis Therapeutics–High-Tech Gründerfonds: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor HTGF 2021-06-15
Alentis Therapeutics–Jeito Capital: investment, 202106 financing round Series B totalling CHF60m incl new + co-investor Jeito Capital 2021-06-15
Alentis Therapeutics–Morningside: investment, 202106 financing round Series B totalling CHF60m incl new + lead investor Morningside Ventures 2021-06-15
Alentis Therapeutics–Schroders: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor Schroders Capital 2021-06-15
Alentis Therapeutics–SEVERAL: investment, 202106 financing round Series B CHF60m led by Morningside Venture Investments 2021-06-15
Allcyte–Exscientia: investment, 202106– acquisition €50m in cash + ordinary shares ANNOUNCED 2021-06-15
VectorY–BioGeneration Ventures: investment, 202106 seed financing round totalling €31m incl co-investor BGV 2021-06-15
VectorY–Forbion: investment, 202106 seed financing round totalling €31m incl co-lead + founding investor Forbion 2021-06-15
VectorY–Instinctif Partners: public relations, 202106 service existent by Instinctif 2021-06-15
VectorY–Lilly: investment, 202106 seed financing round totalling €31m incl co-investor Eli Lilly 2021-06-15
VectorY–OTHER: investment, 202106 seed financing round totalling €31m incl co-lead investor leading global investment firm 2021-06-15
VectorY–SEVERAL: investment, 202106 seed financing round €31m co-led by Forbion + leading global investment firm 2021-06-15
HiFiBio–B Capital Group: investment, 202106 financing round Series D totalling $75m incl new + co-investor B Capital Group 2021-06-14
HiFiBio–Grand Mount: investment, 202106 financing round Series D totalling $75m incl new + co-investor Grand Mount 2021-06-14
HiFiBio–Hengxu: investment, 202106 financing round Series D totalling $75m incl existing + co-investor Hengxu 2021-06-14
HiFiBio–HKSTP Venture Fund: investment, 202106 financing round Series D totalling $75m incl new + co-investor HKSTP Venture Fund 2021-06-14
HiFiBio–IDG Capital: investment, 202106 financing round Series D totalling $75m incl existing + co-investor IDG 2021-06-14
HiFiBio–Legend Star Capital: investment, 202106 financing round Series D totalling $75m incl existing + co-investor Legend Star 2021-06-14
HiFiBio–Maison Capital: investment, 202106 financing round Series D totalling $75m incl new + co-investor Maison Capital 2021-06-14
HiFiBio–Mirae Asset: investment, 202106 financing round Series D totalling $75m incl new + lead investor Mirae Asset Capital 2021-06-14
HiFiBio–Sequoia Capital: investment, 202106 financing round Series D totalling $75m incl existing + co-investor Sequoia Capital China 2021-06-14
HiFiBio–SEVERAL: investment, 202106 financing round Series D $75m led by new investor Mirae Asset Capital 2021-06-14
HiFiBio–Sherpa Healthcare Partners: investment, 202106 financing round Series D totalling $75m incl new + co-investor Sherpa Healthcare Partners 2021-06-14
HiFiBio–Trinity Innovation Fund: investment, 202106 financing round Series D totalling $75m incl new + co-investor TIF 2021-06-14
Quadira Biosciences–Veraxa Biotech: antibody-drug conjugates, 202106– collab developm €na using 3D CoSeedis platform + microfluidics technology 2021-06-14
Atai Life Sciences–SEVERAL: investment, 202106 IPO $225m+$33.75m with 15m+2.25m common shares at $15/share at Nasdaq Global Market 2021-06-11
ITM Isotopen Technologien München–FRIBA Investment: investment, 202106 financing round totalling €25m incl new investor FRIBA Investment 2021-06-10
ITM Isotopen Technologien München–Portland Holdings: investment, 202106 financing round totalling €25m incl investor Portland Holdings 2021-06-10
ITM Isotopen Technologien München–SEVERAL: investment, 202106 financing round €25m private equity incl Portland Holdings + FRIBA Investment 2021-06-10
Advent France Biotechnology–Andrew Lloyd Associates: public relations, 202106 service existent by ALA 2021-06-08
AB Science–Alpha Blue Ocean: investment, before 202106 investment by ABO 2021-06-07
Erytech–Alpha Blue Ocean: investment, before 202106 investment by ABO 2021-06-07
next pagenext page 1 2 3 4 ... 65 66 67  next pagenext page



Advertisement

Picture [iito] Plain Stupid Simple 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px

» top